Characteristics | |
---|---|
Number of patients | 387 |
Age (years), median (IQR) | 47.0 (39.0–54.0) |
Sex, n (%) | |
Male | 370 (95.6) |
Female | 17 (4.4) |
Education levelb, n (%) | |
Primary school/Secondary school | 146 (37.7) |
Vocational school/College of Technology/University | 239 (61.8) |
Missing data | 2 (0.5) |
Employment statusb, n (%) | |
Employed | 308 (79.6) |
Unemployed | 63 (16.3) |
Missing data | 16 (4.1) |
CD4 cell count (cells/µL), median (IQR) | 570 (434–752) |
HIV-RNA < 50 copies/mL, n (%) | |
Yes | 377 (97.4) |
No | 10 (2.6) |
Prior AIDS diagnosisb, n (%) | |
Yes | 124 (32.0) |
No | 262 (67.7) |
Missing data | 1 (0.3) |
Time on ART (years), n (%) | |
< 5 | 121 (31.3) |
5–9 | 122 (31.5) |
≥ 10 | 144 (37.2) |
INSTIs in the current regimenc, n (%) | |
Bictegravir | 203 (52.5) |
Dolutegravir | 162 (41.9) |
Elvitegravir | 22 (5.7) |
Food requirements for the regimen, n (%) | |
Yes | 30 (7.8) |
No | 357 (92.2) |
Number of concomitant medications, n (%) | |
None | 187 (48.3) |
1–4 | 143 (37.0) |
≥ 5 | 57 (14.7) |
Total score of HIVTSQsb, median (IQR) | 59 (53–65) |
Depression leveld, n (%) | |
Minimal | 197 (50.9) |
Mild | 127 (32.8) |
Moderate | 36 (9.3) |
Moderately severe | 20 (5.2) |
Severe | 7 (1.8) |